Kearny EVP reports RSU grants and 150,000 options; small share purchase

Rhea-AI Filing Summary

Thomas DeMedici, EVP and CCO of Kearny Financial Corp. (KRNY), reported transactions dated 08/07/2025. The filing shows an acquisition of 12,240 restricted stock units (RSUs) at a $0 price with a vesting schedule described in the form, and a separate acquisition of 1,879 common shares at a listed price of $5.86. Following the reported transactions the form lists beneficial ownership figures of 82,873 and 80,994 shares on the respective reporting lines. The report also discloses derivative holdings of 100,000 stock options exercisable at $15.35 (expiring 12/01/2026) and 50,000 stock options exercisable at $13.38 (expiring 01/07/2029). Indirect holdings include 48,189 shares via a 401(k), 24,968 via an ESOP, and 786 via a BEP. Explanations in the form state RSUs vest at 33% per year commencing on specified August 7 dates.

Positive

• Acquisition of 1,879 common shares at $5.86 reported on 08/07/2025
• 150,000 stock options disclosed (100,000 at $15.35; 50,000 at $13.38)
• Significant indirect holdings disclosed: 48,189 (401(k)), 24,968 (ESOP), 786 (BEP)

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider reported RSU grants and a small open-market acquisition; 150,000 options outstanding—overall a routine compensation and ownership update.

The Form 4 shows Thomas DeMedici received 12,240 RSUs (priced $0) with staged vesting and acquired 1,879 shares at $5.86 on 08/07/2025. The report additionally lists 100,000 and 50,000 stock options with stated exercise prices and expirations. Indirect plan holdings are disclosed for 401(k), ESOP and BEP accounts. From an investor perspective, these are factual disclosures of compensation and holdings; the filing does not by itself indicate a material change to capitalization or a corporate event.

Corporate Governance Expert

TL;DR: Filing documents multi-year RSU vesting vintages and retirement-plan holdings, reflecting executive compensation structure rather than a material corporate action.

The explanations explicitly state RSUs vest at a rate of 33% per year commencing on specified August 7 dates, indicating staged compensation recognition across multiple grant years. The presence of 48,189 shares held indirectly in a 401(k) and 24,968 via an ESOP is documented. The filing is a standard Section 16 disclosure showing ownership and option positions; it contains no disclosures of leadership change, securitization, or litigation that would alter governance assessment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeMedici Thomas

(Last) (First) (Middle)

C/O KEARNY FINANCIAL CORP.

120 PASSAIC AVENUE

(Street)

FAIRFIELD NJ 07004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kearny Financial Corp. [ KRNY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CCO

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2025		A		12,240(1)	A	$0	82,873(2)(3)(4)	D
Common Stock	08/07/2025		F		1,879	D	$5.86	80,994(2)(3)(4)	D
Common Stock								48,189(5)	I	By 401(k)
Common Stock								24,968(5)	I	By ESOP
Common Stock								786(5)	I	By BEP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$15.35							12/01/2017	12/01/2026	Common Stock	100,000		100,000	D
Stock Options	$13.38							01/07/2020	01/07/2029	Common Stock	50,000		50,000	D

Explanation of Responses:

1. Restricted stock units which vest at a rate of 33% per year commencing on August 7, 2026.

2. Includes restricted stock units which vest at a rate of 33% per year commencing on August 7, 2025.

3. Includes restricted stock units which vest at a rate of 33% per year commencing on August 7, 2024.

4. Includes restricted stock units which vest at a rate of 33% per year commencing on August 7, 2023.

5. Reflects transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.

Remarks:

	/s/ Gail Corrigan, pursuant to power of attorney	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for KRNY?

The reporting person is Thomas DeMedici, identified as EVP and CCO of Kearny Financial Corp.

What transactions did the KRNY reporting person make on 08/07/2025?

The form lists an acquisition of 12,240 RSUs at $0 (with vesting schedule) and an acquisition of 1,879 common shares at $5.86.

How many stock options does the KRNY reporting person hold?

The filing discloses 100,000 options at an exercise price of $15.35 (exercisable 12/01/2026) and 50,000 options at $13.38 (exercisable 01/07/2029).

What RSU vesting schedule is disclosed in the KRNY Form 4?

Explanations state RSUs vest at a rate of 33% per year commencing on the August 7 date specified for each grant vintage.

Are there indirect holdings reported for the KRNY insider?

Yes. The form reports indirect holdings of 48,189 shares via a 401(k), 24,968 via an ESOP, and 786 via a BEP.